RaySearch Collaborates with AKSM/Oncology for New Cancer Treatment Center
RaySearch Laboratories AB (publ) is thrilled to announce a new partnership with AKSM/Oncology. This partnership will employ the innovative RayCare oncology information system and the highly regarded RayStation treatment planning system at a state-of-the-art cancer treatment center. The center is part of Advanced Radiation Therapeutics (ART) and aims to revolutionize cancer treatment using advanced technology.
Overview of the New Radiation Therapy Center Initiative
The ART center is designed as a multidisciplinary facility dedicated to providing exceptional oncology care. It represents a significant step in AKSM/Oncology’s commitment to improving cancer care through partnerships with various medical groups. This initiative will mark the establishment of over 20 freestanding radiotherapy centers nationwide by AKSM.
Features of the New Facility
ART will utilize the latest technology in radiation treatment, including RayStation, in conjunction with Varian TrueBeam linear accelerators. This setup will facilitate efficient treatment workflows. Notably, RayCare 2024A has obtained market clearance in the U.S. and is lauded for its ability to work seamlessly with all Varian TrueBeam systems.
Benefits of RayCare and RayStation Integration
The integration of RayCare with RayStation offers a fully streamlined workflow from the initial treatment prescription to the final delivery, minimizing manual steps and enhancing operational safety. By harnessing the capabilities of RayStation, patients will benefit from advanced treatment planning options—this includes technologies like 3D planning, IMRT, and VMAT, along with specialized radiation techniques.
Leadership Insights on the Partnership
Scott Neal, the President of AKSM/Oncology and a Board Member at Advanced Radiation Therapeutics, expressed enthusiasm about this collaboration, stating, "Partnering with RaySearch to utilize their oncology information and treatment planning systems is a vital part of our mission to deliver advanced patient care. We admire their commitment to innovation in oncology treatment systems, and together we aim to enhance patient outcomes significantly."
Johan Löf, founder and CEO of RaySearch Laboratories, echoed these sentiments, highlighting RayCare’s growing influence: "The positive traction RayCare is gaining in the U.S. underscores our commitment to providing a unified treatment planning and information system. We are confident that combining RayCare and RayStation with TrueBeam will lead to heightened efficiency and improved patient care quality at the ART facility."
Looking Ahead: Timing and Impact
The order for this collaboration was finalized in the second quarter of 2025, with anticipated revenue recognition expected over the subsequent eight months as the department prepares for go-live. These actions reflect the forward momentum and dedication to establishing a new standard in cancer care.
Frequently Asked Questions
What is the primary goal of the new cancer treatment center?
The primary goal is to provide advanced, comprehensive radiation therapy to oncology patients, utilizing state-of-the-art technologies.
What systems will be integrated into the new facility?
The facility will feature RayCare and RayStation systems, alongside Varian TrueBeam linear accelerators.
How does RayCare enhance patient treatment?
RayCare streamlines the workflow from treatment prescription to delivery, improving safety and efficiency.
Who are the key partners in this initiative?
RaySearch Laboratories and AKSM/Oncology are the key partners driving this initiative forward.
What timeline is anticipated for the launch of the facility?
The new center is expected to open in early 2026, following a comprehensive development phase.
